Mechanisms of tuberculosis chemotherapy

Journal of Pharmacy and Pharmacology

Volumn 49, Issue SUPPL. 1, 1997, Pages 31-36

  Mitchison, D A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; METRONIDAZOLE; PYRAZINAMIDE; RIFAMPICIN; RIFATER; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS;

EID: 0030903769     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06147.x     Document Type: Conference Paper

References (24)

1. Botha, F. J. H., Sirgel, F. A., Parkin, D. P., Van de Wal, B. W., Donald, P. R., Mitchison, D. A. (1996) Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. S. Afr. Med. J. 86: 155-158
2. Canetti, G. J. (1955) The Tubercle Bacillus in the Pulmonary Lesions of Man; Histobacteriology and its Bearing on the Therapy of Pulmonary Tuberculosis. Springer, New York, 62-68
3. Crowle, A. J., Sbarbaro, J. A., May, M. H. (1986) Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages. Am. Rev. Respir. Dis. 134: 1052-1055
4. Dhillon, J., Mitchison, D. A. (1989) Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig. Br. J. Exp. Pathol. 70: 103-110
5. Dickinson, J. M., Mitchison, D. A. (1981) Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am. Rev. Respir. Dis. 123: 367-371
6. Dickinson, J. M., Mitchison, D. A. (1987) In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosis. Tubercle 68: 183-193
7. Dickinson, J. M., Mitchison, D. A. (1990) In vitro activities against mycobacteria of two long-acting rifamycins, FCE22807 and CGP40469A (SPA-S-565). Tubercle 71: 109-115
8. East African/British Medical Research Council (1974) Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet ii: 237-40
9. Grosset, J. (1978) The sterilizing value of rifampicin and pyrazinamide in experimental short course chemotherapy. Bull. Int. Un. Tuberc. 53: 5-12
10. Heifets, L., Lindholm-Levy, P. (1992) Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am. Rev. Respir. Dis. 145: 1223-1225
11. Herbert, D., Paramasivan, C. N., Venkatesan, P., Kubendiran, G., Prabhakar, R., Mitchison, D. A. (1996) Bactericidal action of ofloxacin, sulbactamampicillin, rifampicin and isoniazid, on logarithmic and stationary phase cultures of M. tuberculosis. Antimicrob. Agents Chemother. 40: 2296-2299
12. Jindani, A., Aber, V. R., Edwards, E. A., Mitchison, D. A. (1980) The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 121: 939-949
13. Khor, M., Lowrie, D. B., Coates, A. R. M., Mitchison, D. A. (1986) Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis. Br. J. Exp. Pathol. 67: 587-596
14. Konno, K., Feldmann, F. M., McDermott, W. (1967) Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am. Rev. Respir. Dis. 95: 461-469
15. McCune, R. M., Feldmann, F. M., Lambert, H. P., McDermott, W. (1956) The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104: 763-802
16. McDermott, W., Tompsett, R. (1954) Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am. Rev. Tuberc. 70: 748-754
17. Mitchison, D. A., (1985) The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66: 219-225
18. Rastogi, N., Potar, M.-C., David, H. L. (1988) Pyrazinamide is not effective against intracellularly growing Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 32: 287
19. Scorpio, A., Zhang, Y. (1996) Mutations in pncA, a gene encoding pyrazinamidasenicotinamidase, cause resistance to antituberculous drug pyrazinamide in tubercle bacillus. Nature Med. 2: 662-667
20. Sirgel, F. A., Botha, F. J. H., Parkin, D. P., Van de Wal, B. W., Donald, P. R., Clark, P. K., Mitchison, D. A. (1993) The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts. J. Antimicrob. Chemother. 32: 867-75
21. Wayne, L. G. (1994) Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13: 908-914
22. Wayne, L. G., Sramek, H. A. (1994) Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38: 2054-2058
23. Wayne, L. G., Hayes, L. G. (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64: 2062-2069
24. Wirth, R., Muscholl, A., Wanner, G. (1996) The role of pheromones in bacterial interactions. Trends Microbiol. 4: 96-100